Aspira Pathlab & Diagnostics Ltd

NSE: ASPIRA · BSE: 540788 · Healthcare · 31 announcements

Share price: ₹113.25
Market cap: ₹116.6 Cr
Revenue (annual): ₹24.98 Cr
Net profit (annual): ₹0.05 Cr
P/E (TTM): -257.6×Sector 53.1×
Promoter holding: 46.58%+28.19% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

7 Apr 2026 15:43 IST BSE

Aspira Pathlab & Diagnostics Open Offer: ₹14.72 Cr

Arvind Karsandas Bhanushali and others have launched an open offer to acquire a 26% stake in Aspira Pathlab & Diagnostics Limited at ₹55 per share. The total offer size is ₹14.72 Crore. The tendering period is scheduled from April 15 to April 28, 2026, following a substantial acquisition and change in control.

Value: ₹14.72 Cr
Execution: Tendering Period: April 15, 2026 to April 28, 2026

Read the filing ↗